Download PDF
Journal of Pediatric Neurology 2024; 22(01): 060-063
DOI: 10.1055/s-0042-1760196
Case Report

Limb Hypertrophy—An Uncommon Presentation Yet a Common Link among Neurocutaneous Syndromes: A Series of Three Cases

Akriti Agrawal 
1   Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
,
Anil Budania
1   Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
,
Lokesh Saini
2   Department of Pediatrics, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
,
Sarbesh Tiwari
3   Department of Radiology, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
,
Deepak Vedant
4   Department of Pathology, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
,
Benetta Benny
1   Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Limb hypertrophy is an unusual presentation associated with neurocutaneous syndromes. The mechanism behind this presentation may vary from case to case. Here, we describe a case series of three different syndromes linked by a common clinical finding of limb hypertrophy.

Keywords

neurocutaneous syndromes - limb hypertrophy - mTOR

Written Informed Consent

Written informed consent has been obtained from the patients for publication purposes.




Publication History

Received: 26 July 2022

Accepted: 20 November 2022

Article published online:
30 December 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Keppler-Noreuil KM, Rios JJ, Parker VE. et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 2015; 167A (02) 287-295
    CrossrefPubMedGoogle Scholar
  • 2 Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med 2010; 12 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 3 Stevenson DA, Viskochil DH, Rope AF, Carey JC. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype. Clin Genet 2006; 69 (03) 246-253
    CrossrefPubMedGoogle Scholar
  • 4 Nyström AM, Ekvall S, Allanson J. et al. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1. Clin Genet 2009; 76 (06) 524-534
    CrossrefPubMedGoogle Scholar
  • 5 Ponti G, Pellacani G, Martorana D. et al. Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: a case report. Oncol Lett 2016; 11 (06) 3709-3714
    CrossrefPubMedGoogle Scholar
  • 6 Jenkins D, McCuaig C, Drolet BA. et al. Tuberous sclerosis complex associated with vascular anomalies or overgrowth. Pediatr Dermatol 2016; 33 (05) 536-542
    CrossrefPubMedGoogle Scholar
  • 7 Reddy BSN, Sheriff MO, Garg BR, Ratnakar C. A rare association of localized gigantism with tuberous sclerosis. J Dermatol 1992; 19 (10) 622-625
    CrossrefPubMedGoogle Scholar
  • 8 Hirsch RJ, Silverberg NB, Laude T, Weinberg JM. Tuberous sclerosis associated with congenital lymphedema. Pediatr Dermatol 1999; 16 (05) 407-408
    CrossrefPubMedGoogle Scholar
  • 9 Voudris KA, Skardoutsou A, Vagiakou EA. Tuberous sclerosis and congenital lymphedema. Pediatr Dermatol 2003; 20 (04) 371-373
    CrossrefPubMedGoogle Scholar
  • 10 Lucas M, Andrade Y. Congenital lymphedema with tuberous sclerosis and clinical Hirschsprung disease. Pediatr Dermatol 2011; 28 (02) 194-195
    CrossrefPubMedGoogle Scholar
  • 11 Purkait R, Samanta T, Sinhamahapatra T, Chatterjee M. Overlap of sturge-weber syndrome and klippel-trenaunay syndrome. Indian J Dermatol 2011; 56 (06) 755-757
    CrossrefPubMedGoogle Scholar
  • 12 Rao AG, Reddy VS, Parimala MD. et al. Sturge-Weber syndrome coexisting with multiple vertebral vascular malformations and hemivertebra with scoliosis and upper limb and ear hypertrophy. Indian J Dermatol Venereol Leprol 2020; 86 (02) 187-190
    CrossrefPubMedGoogle Scholar
  • 13 Giacaman A, Salinas Sanz JA, Navarro Noguera S, Lastra Rodríguez J, Montis Palos MC, Martín-Santiago A. Facial hemihypertrophy in a girl with sturge-weber syndrome: treatment with oral sirolimus. Pediatr Dermatol 2021; 38 (02) 469-471
    CrossrefPubMedGoogle Scholar
  • 14 Vahidnezhad H, Youssefian L, Uitto J. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS). Exp Dermatol 2016; 25 (01) 17-19
    CrossrefPubMedGoogle Scholar
  • 15 Gross AM, Wolters PL, Dombi E. et al. Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med 2020; 382 (15) 1430-1442
    CrossrefPubMedGoogle Scholar
  • 16 Blegen K, Ortiz-Romero SE, Juarez O, Voeller J. Clinical impact of selumetinib on pediatric elephantiasis neuromatosa. Pediatr Dermatol 2022; 39 (05) 764-766
    CrossrefPubMedGoogle Scholar
  • 17 Franz DN, Krueger DA. mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex. Am J Med Genet C Semin Med Genet 2018; 178 (03) 365-373
    CrossrefPubMedGoogle Scholar